Works matching IS 0920-3206 AND VI 39 AND IP 3 AND DT 2025

Results: 22

MOTS-c: Magical Molecule for Diabetic Cardiomyopathy?

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 473, doi. 10.1007/s10557-025-07689-y

By:

Yerra, Veera Ganesh;
Connelly, Kim A.

Publication type:

Article

Letter to the Editor Regarding the SELECT Trial.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 701, doi. 10.1007/s10557-025-07686-1

By:

Penteris, Michail;
Lampropoulos, Konstantinos

Publication type:

Article

Editorial to "A Plant-Powered Remedy: Hyperoside's Potential Against Trastuzumab-Induced Cardiotoxicity" by Bullock et al.

Published in:

2025

By:

Bullock, Zaniqua N.;
Wehrens, Xander H. T.;
Young, Damian W.

Publication type:

Editorial

Post-TEVAR Type A Aortic Dissection: Insights and Future Directions.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 697, doi. 10.1007/s10557-025-07681-6

By:

Wang, Jessica K.;
Wehrens, Xander H. T.;
Grande-Allen, K. Jane

Publication type:

Article

GLP-1 Receptor Agonists and Cardiac Health: Insights from a Systematic Review.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 699, doi. 10.1007/s10557-025-07680-7

By:

Pedrosa, Mauricio Reis;
da Silva, Arnaldo Alves;
Trevisani, Virginia Fernandes Moça

Publication type:

Article

The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 573, doi. 10.1007/s10557-024-07570-4

By:

Gu, Jun;
Han, Zhi-Hua;
Wang, Chang-qian;
Zhang, Jun-feng

Publication type:

Article

Aloperine Alleviates Myocardial Injury Induced by Myocardial Ischemia and Reperfusion by Activating the ERK1/2/β-catenin Signaling Pathway.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 533, doi. 10.1007/s10557-024-07566-0

By:

Wei, Shichao;
Ju, Feng;
Xiao, Junshen;
Li, Jiaxue;
Liu, Ting;
Hu, Zhaoyang

Publication type:

Article

Surgical Treatment for Type A Aortic Dissection after Endovascular Aortic Repair: A 12-year, Single-Center Study.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 583, doi. 10.1007/s10557-024-07565-1

By:

Xue, Yuan;
Wang, Shipan;
Zhang, Xuehuan;
Wang, Xiaomeng;
Shi, Yue;
Zhang, Hongjia;
Chen, Duanduan;
Li, Haiyang

Publication type:

Article

Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 563, doi. 10.1007/s10557-024-07558-0

By:

Xu, Qiuyu;
Chen, Gang;
Ai, Sanxi;
Zheng, Ke;
Zhao, Bin;
Li, Xuemei

Publication type:

Article

An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 517, doi. 10.1007/s10557-024-07555-3

By:

Liu, Sa;
Liu, Jiaqin;
Su, Nan;
Wei, Shanshan;
Xie, Ning;
Li, Xiangyun;
Xie, Suifen;
Liu, Jian;
Zhang, Bikui;
Li, Wenqun;
Tan, Shengyu

Publication type:

Article

Comparison Between Drug-Coated Balloon and Stents in Large De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis of RCT Data.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 677, doi. 10.1007/s10557-024-07548-2

By:

Ma, Zhiqiang;
Liu, Kanling;
Hu, Yanhui;
Hu, Xiwen;
Wang, Binyu;
Li, Zhengyi

Publication type:

Article

Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 553, doi. 10.1007/s10557-024-07546-4

By:

Irizarry-Caro, Jorge A.;
Song, Juhee;
Miller, Chase;
Desai, Shyam;
Going, James;
Fossas-Espinosa, Jose;
Fatakdawala, Mariya M.;
Ali, Abdelrahman;
Iliescu, Cezar;
Palaskas, Nicolas;
Deswal, Anita;
Koutroumpakis, Efstratios

Publication type:

Article

Metabolism Serves as a Bridge Between Cardiomyocytes and Immune Cells in Cardiovascular Diseases.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 661, doi. 10.1007/s10557-024-07545-5

By:

Hang, Lixiao;
Zhang, Ying;
Zhang, Zheng;
Jiang, Haiqiang;
Xia, Lin

Publication type:

Article

The Infarct-Limiting Effect of Remote Ischemic Conditioning in Rats Is Not Affected by Aspirin.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 691, doi. 10.1007/s10557-023-07541-1

By:

Basalay, M. V.;
Downey, James M.;
Davidson, S. M.;
Yellon, D. M.

Publication type:

Article

MOTS-c Peptide Attenuated Diabetic Cardiomyopathy in STZ-Induced Type 1 Diabetic Mouse Model.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 491, doi. 10.1007/s10557-023-07540-2

By:

Wu, Nan;
Shen, Caijie;
Wang, Jian;
Chen, Xiaomin;
Zhong, Peng

Publication type:

Article

Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Low Body Weight Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 643, doi. 10.1007/s10557-023-07537-x

By:

Elshafei, Mohamed Nabil;
Salem, Muhammad;
El-Bardissy, Ahmed;
Abdelmoneim, Mohamed S.;
Khalil, Ahmed;
Elhadad, Sherine;
Al Mistarihi, Mutasem;
Danjuma, Mohammed

Publication type:

Article

The Toll-like Receptor-2/4 Antagonist, Sparstolonin B, and Inflammatory Diseases: A Literature Mining and Network Analysis.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 499, doi. 10.1007/s10557-023-07535-z

By:

Yang, Rongyuan;
Liu, Qingqing;
Wang, Dawei;
Zhao, Zhen;
Su, Zhaohai;
Fan, Daping;
Liu, Qing

Publication type:

Article

Interplay Between TGF-β Signaling and MicroRNA in Diabetic Cardiomyopathy.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 633, doi. 10.1007/s10557-023-07532-2

By:

Qin, Jianning;
Tan, Yao;
Han, Yang;
Yu, Letian;
Liu, Shali;
Zhao, Simin;
Wan, Hengquan;
Qu, Shunlin

Publication type:

Article

ROS-Activated TRPM2 Channel: Calcium Homeostasis in Cardiovascular/renal System and Speculation in Cardiorenal Syndrome.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 615, doi. 10.1007/s10557-023-07531-3

By:

Chen, Zihan;
Cheng, Zaihua;
Ding, Congcong;
Cao, Tianyu;
Chen, Ling;
Wang, Hong;
Li, Junpei;
Huang, Xiao

Publication type:

Article

Hyperoside Protects Trastuzumab-Induced Cardiotoxicity via Activating the PI3K/Akt Signaling Pathway.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 481, doi. 10.1007/s10557-023-07522-4

By:

Wei, Shanshan;
Ma, Wanjun;
Xie, Suifen;
Liu, Sa;
Xie, Ning;
Li, Wenqun;
Zhang, Bikui;
Liu, Jian

Publication type:

Article

Therapeutic Approaches Targeting Ferroptosis in Cardiomyopathy.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 595, doi. 10.1007/s10557-023-07514-4

By:

Ruan, Yanqian;
Zhang, Ling;
Zhang, Lina;
Zhu, Keyang

Publication type:

Article

Early Initiation of SGLT2 Inhibitors in Acute Heart Failure: a Focus on Diuresis and Renal Protection.

Published in:

Cardiovascular Drugs & Therapy, 2025, v. 39, n. 3, p. 687, doi. 10.1007/s10557-023-07512-6

By:

Hammer, Andreas;
Niessner, Alexander;
Sulzgruber, Patrick

Publication type:

Article